期刊的影响因子--文章列表

期刊文章列表
薛梦侠，古悦，孙建国，王广基，彭英（中国药科大学药物代谢动力学重点实验室）.去势抵抗前列腺癌中的非激素信号通路作用机制及其相关药物研究进展[J].药学学报,2021,第1期姚开云，丁虹琬，曹琳玉，高银阁，张建军，王贵彬（中国医学科学院北京协和医学院药物研究所新药作用机制研究和药效评价北京市重点实验室）.组蛋白去乙酰化酶抑制剂的抗抑郁前景[J].药学学报,2021,第1期高悦，王晓萍，李敏，窦仁捷，强磊（中国药科大学基础医学与临床药学学院天然药物国家重点实验室）.天然产物在黑色素瘤防治中的研究进展[J].药学学报,2021,第1期陈诗宇^1,2，赖伟华¹，钟诗龙^1,2,3（广东省人民医院(广东省医学科学院)药学部；华南理工大学生物科学与工程学院；广东省人民医院(广东省医学科学院)广东省冠心病防治研究重点实验室）.新靶点三磷酸腺苷柠檬酸裂解酶（ACLY）抑制剂用于降血脂的研究进展[J].药学学报,2021,第1期王建涛¹，曾荟珊²，韦珍²，陈亮³（河南医药技师学院；河南大学药学院；河南大学天然药物与免疫工程重点实验室）.黄芩素通过ERK/ELK-1/Snail信号通路抑制食管鳞癌细胞转移的机制[J].药学学报,2021,第1期 Chen Xiaofei，Wu Yunlong，Chen Chun，Gu Yanqiu，Zhu Chunyan，Wang Suping，Chen Jiayun，Zhang Lei，Lv Lei，Zhang Guoqing，Yuan Yongfang，Chai Yifeng，Zhu Mingshe，Wu Caisheng.Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening[J].药学学报,2021,第1期 Song Zhendong，Wang Meijing，Ge Yang，Chen Xueping，Xu Ziyang，Sun Yang，Xiong Xiaofeng.Tyrosine phosphatase SHP2 inhibitors in tumortargeted therapies[J].药学学报,2021,第1期 Yuan Kai，Wang Xiao，Dong Haojie，Min Wenjian，Hao Haiping，Yang Peng.Selective inhibition of CDK4/6:A safe and effective strategy for developing anticancer drugs[J].药学学报,2021,第1期 Duan Hongxia，Liu Yanhong，Gao Zhonggao，Huang Wei.Recent advances in drug delivery systems for targeting cancer stem cells[J].药学学报,2021,第1期 Yan Zhibin，Wang Dan，An Chunmei，Xu Hongjiao，Zhao Qian，Shi Ying，Song Nazi，Deng Bochuan，Guo Xiaomin，Rao Jing，Cheng Lu，Zhang Bangzhi，Mou Lingyun，Yang Wenle，Jiang Xianxing，Xie Junqiu.The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis[J].药学学报,2021,第1期 Ye Jiezhou，Zeng Bo，Zhong Meiyan，Li Hongchun，Xu Lihui，Shu Junxiang，Wang Yaofeng，Yang Fan，Zhong Chunsu，Ye Xunjia，He Xianhui，Ouyang Dongyun.Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages via regulating PKA signaling[J].药学学报,2021,第1期 Cheny Jie，Wangy Yan，Zhao Di，Zhang Lingyuan，Zhang Weimin，Fan Jiawen，Li Jinting，Zhan Qimin.Chrysin serves as a novel inhibitor of DGKalpha/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)[J].药学学报,2021,第1期 Zhang Shun，Zhao Yan，Wang Shuyuan，Li Min，Xu Yue，Ran Jianhua，Geng Xiaoqiang，He Jinzhao，Meng Jia，Shao Guangying，Zhou Hong，Ge Zemei，Chen Guangping，Li Runtao，Yang Baoxue.Discovery of novel diarylamides as orally active diuretics targeting urea transporters[J].药学学报,2021,第1期 Zhao Bing，Zhang Xinhui，Yu Tingting，Liu Ying，Zhang Xiaoling，Yao Yongfang，Feng Xuejian，Liu Hongmin，Yu Dequan，Ma Liying，Qin Shangshang.Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-beta-lactamase-1 (NDM-1)inhibitors against NDM-1 producing clinical isolates[J].药学学报,2021,第1期 Gao Xiaopan，Qin Bo，Chen Pu，Zhu Kaixiang，Hou Pengjiao，Wojdyla Justyna Aleksandra，Wang Meitian，Cui Sheng.Crystal structure of SARS-CoV-2 papain-like protease[J].药学学报,2021,第1期 Zhang Bingchen，Jiang Jiali，Wu Pengyu，Zou Junjie，Le Jingqing，Lin Juanfang，Li Chao，Luo Bangyue，Zhang Yongjie，Huang Rui，Shao Jingwei.A smart dual-drug nanosystem based on coassembly of plant and food-derived natural products for synergistic HCC immunotherapy[J].药学学报,2021,第1期林娇^1,2，林璐瑶²，吴征²，杨雪晗¹，周欣¹，张佳良¹（福建医科大学福总临床医学院(联勤保障部队第九〇〇医院)药剂科；福建医科大学药学院）.共载5-氨基酮戊酸及二氧化碳的氟碳微乳凝胶的制备及质量评价[J].药学学报,2021,第1期侯嘉铭¹，尹彦超²，田少凯¹，张智新¹，杨林¹，李文东³，刘颖¹（北京中医药大学生命科学学院；华中科技大学同济医学院附属同济医院药学部；北京市药品检验所）.过表达CHI基因提高甘草毛状根中黄酮类化合物含量的研究[J].药学学报,2021,第1期 Changy Xiaosa，Suny Dejuan，Shiy Danfeng，Wang Guan，Chen Yanmei，Zhang Kai，Tan Huidan，Liu Jie，Liu Bo，Ouyang Liang.Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose)polymerase-1 and bromodomain containing protein 4 for breast cancer therapy[J].药学学报,2021,第1期 Zhou Shuang，Li Jinbo，Yu Jiang，Yang Liyuan，Kuang Xiao，Wang Zhenjie，Wang Yingli，Liu Hongzhuo，Lin Guimei，He Zhonggui，Liu Dan，Wang Yongjun.A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect[J].药学学报,2021,第1期 Chen Xiaojie，Zou Jiafeng，Zhang Ke，Zhu Jingjing，Zhang Yue，Zhu Zhihong，Zheng Hongyue，Li Fanzhu，Piao Jigang.Photothermal/matrix metalloproteinase-2 dualresponsive gelatin nanoparticles for breast cancer treatment[J].药学学报,2021,第1期 Li Jinyang，Lu Jiasheng，Guo Haiyan，Zhou Jianfen，Wang Songli，Jiang Kuan，Chai Zhilan，Yao Shengyu，Wang Xiaoyi，Lu Linwei，Xie Cao，Chen Yi，Lu Weiyue.A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated[J].药学学报,2021,第1期 Zeng Hao，Wang Lingling，Zhang Jiawei，Pan Ting，Yu Yinghua，Lu Jingxia，Zhou Ping，Yang Hua，Li Ping.Activated PKB/GSK-3beta synergizes with PKC-delta signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity:Therapeutic efficacy of dihydrotanshinone-I[J].药学学报,2021,第1期 Zhou Yanying，Fan Xiaomei，Jiao Tingying，Li Wenzhou，Chen Panpan，Jiang Yiming，Sun Jiahong，Chen Yixin，Chen Pan，Guan Lihuan，Wen Yajie，Huang Min，Bi Huichang.SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation[J].药学学报,2021,第1期 Bian Jingwei，Li Zijian.Angiotensin-converting enzyme 2 (ACE2):SARS-CoV-2 receptor and RAS modulator[J].药学学报,2021,第1期 Shen Yilan，Chen Wei，Han Lei，Bian Qi，Fan Jiajun，Cao Zhonglian，Jin Xin，Ding Tao，Xian Zongshu，Guo Zhiyong，Zhang Wei，Ju Dianwen，Mei Xiaobin.VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses[J].药学学报,2021,第1期宣婧婧^1,2，武喜营³，戚建平⁴，庄婕^2,5（上海中医药大学研究生院；上海健康医学院药学院；上海皮肤病医院；复旦大学药学院；上海中医药大学）.天然低共熔溶剂在药剂学中的应用[J].药学学报,2021,第1期邓文斌¹，潘昊²，李云建¹，乔森¹，周晓彤¹，潘卫三¹（沈阳药科大学药学院；辽宁大学药学院）.2208型羟丙甲纤维素功能性相关指标的考察与主成分分析[J].药学学报,2021,第1期郭宗儒（中国医学科学院，北京协和医学院药物研究所）.精准研制的非小细胞肺癌治疗药布加替尼[J].药学学报,2021,第1期李欣濛，李佳月，张欣，田晟吉，肖士超，姚梦雨，刘丹青，郭英（哈尔滨理工大学化学与环境工程学院）.纳米黑磷在光疗和药物载体方面的研究与应用[J].药学学报,2021,第1期首页上一页 21 22 23 24 下一页尾页共有24页，转到页

期刊文章列表